The renewals complement existing agreements for hematology, flow cytometry and coagulation systems, already on contract with MedAssets. Mary Ellen Kimmeth, MedAssets vice president of laboratory division and capital
The results from the MERLIN TIMI-36 study confirm that Renexa is a safe and effective anti-ischemic drug that also has favorable effects on arrhythmia and hemoglobin A1c, according
The integration uses Boston Scientific’s Latitude patient management system to allow clinicians to access information from a patient’s implanted cardiac device and store within the GE Centricity electronic
The option was granted in connection with Nanosphere’s initial public offering of 7,000,000 shares. The closing of the sale of all 8,050,000 shares by Nanosphere to the underwriters
The Phase Ib study of GI-5005 demonstrated strong trends for a dose-dependent response in patients that normalize their ALT (a marker of liver damage) compared with placebo, ranging
While there was a statistically significant improvement in NYHA class, a secondary endpoint, there was no improvement in quality-of-life, six-minute walk or echocardiographic measures in the patients who
This approval is based on results from a six-week, randomized, double- blind, placebo-controlled study that demonstrated significant improvement with Abilify compared to placebo on the primary efficacy endpoint,
This Phase II study was designed to assess the pharmacokinetics, safety and efficacy of MTR106 in female patients suffering from migraine without aura. The study population consisted of
The data showed that RB006 completely inhibited the activity of factor IXa, a protein essential to blood clotting, and RB006’s activity was rapidly and safely reversed by RB007
The study shows that fenofibrate decreases the need for laser therapy for diabetic eye disease by more than 30%. In addition to reducing the need for laser therapy
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.